Publication & Citation Trends
Publications
0 total
a of Assessment of bone response to systemic therapy in an trial: preliminary with the use of cross-link
Cited by 32
Semantic Scholar
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01) OA
Cited by 105
Semantic Scholar
Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer
Cited by 9
Semantic Scholar
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. OA
Cited by 17
Semantic Scholar
Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Cited by 382
Semantic Scholar
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study
Cited by 41
Semantic Scholar
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Cited by 210
Semantic Scholar
Research Topics
Bone health and treatments
(22)
Cancer Treatment and Pharmacology
(14)
Breast Cancer Treatment Studies
(13)
Cancer Diagnosis and Treatment
(12)
HER2/EGFR in Cancer Research
(10)
Affiliations
Semmelweis University
Universidade Federal do Rio Grande do Sul
Santa Casa Hospital
Yorkshire Cancer Research
Hospital de Sant Pau